Performance of coagulation tests in patients on therapeutic doses of rivaroxaban
E. M. Hawes(University of North Carolina at Chapel Hill), Suzanne J. Francart(University of North Carolina Health Care), Kenneth D. Friedman(Versiti Blood Center of Wisconsin), Robert C. Gosselin(University of California Davis Medical Center), Dorothy M. Adcock(Esoterix), Allison M. Deal(UNC Lineberger Comprehensive Cancer Center), C. Jeanneret(University of North Carolina at Chapel Hill), Stephan Moll(University of North Carolina at Chapel Hill)
Cited by 107
Related Papers
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
|New England Journal of Medicine|2017|851
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2003|809
Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
|Journal of Thrombosis and Haemostasis|2016|442
Inherited antithrombin deficiency: a review
|Haemophilia|2008|396
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
|American Journal of Hematology|2012|366